Literature DB >> 6792747

Effect of monocrotaline ingestion on liver, kidney, and lung of rats.

R A Roth, L A Dotzlaf, B Baranyi, C H Kuo, J B Hook.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6792747     DOI： 10.1016/0041-008x(91)90223-2

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  5 in total

1.  Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline.

Authors:  W M Lafranconi; R J Huxtable
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

2.  Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats.

Authors:  Daniel J Lachant; David F Meoli; Deborah Haight; Jason A Lyons; Robert F Swarthout; R James White
Journal:  Exp Lung Res       Date:  2018-01-30       Impact factor: 2.459

3.  Energy Metabolism in the Failing Right Ventricle: Limitations of Oxygen Delivery and the Creatine Kinase System.

Authors:  Ewan D Fowler; David Hauton; John Boyle; Stuart Egginton; Derek S Steele; Ed White
Journal:  Int J Mol Sci       Date:  2019-04-12       Impact factor: 6.208

4.  Magnesium Sulfate Mitigates the Progression of Monocrotaline Pulmonary Hypertension in Rats.

Authors:  Chao-Yuan Chang; Hung-Jen Shih; I-Tao Huang; Pei-Shan Tsai; Kung-Yen Chen; Chun-Jen Huang
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

5.  Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition.

Authors:  Rui-Xing Wang; Rui-Lan He; Hai-Xia Jiao; Run-Tian Zhang; Jing-Yi Guo; Xiao-Ru Liu; Long-Xin Gui; Mo-Jun Lin; Zhi-Juan Wu
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.